A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses

Rapid development of COVID-19 vaccines has helped mitigating SARS-CoV-2 spread, but more equitable allocation of vaccines is necessary to limit the global impact of the COVID-19 pandemic and the emergence of additional variants of concern. We have developed a COVID-19 vaccine candidate based on Newc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Weina, Liu, Yonghong, Amanat, Fatima, González-Domínguez, Irene, McCroskery, Stephen, Slamanig, Stefan, Coughlan, Lynda, Rosado, Victoria, Lemus, Nicholas, Jangra, Sonia, Rathnasinghe, Raveen, Schotsaert, Michael, Martinez, Jose L., Sano, Kaori, Mena, Ignacio, Innis, Bruce L., Wirachwong, Ponthip, Thai, Duong Huu, Oliveira, Ricardo Das Neves, Scharf, Rami, Hjorth, Richard, Raghunandan, Rama, Krammer, Florian, García-Sastre, Adolfo, Palese, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551302/
https://www.ncbi.nlm.nih.gov/pubmed/34707161
http://dx.doi.org/10.1038/s41467-021-26499-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551302/
https://www.ncbi.nlm.nih.gov/pubmed/34707161
http://dx.doi.org/10.1038/s41467-021-26499-y

Ejemplares similares